A petition to cancel the incoming Tokyo Olympics was sent..
A different kind of clinical trial is introduced in our battle against the COVID-19 pandemic.
In a televised meeting with President Rodrigo R. Duterte, the Department of Science and Technology (DOST) announced on April 18, 2021 (Monday) that the country is preparing to conduct clinical trials for the use of ivermectin in our battle against COVID-19.
According to DOST chief Fortunato dela Peña, he and Health Secretary Francisco Duque III discussed the issue after Duterte raised it in a meeting last April 15, 2021 (Thursday). On April 17, 2021 (Saturday), the issue was agreed upon the notion that an expert would lead the clinical trials.
Ivermectin clinical trial
It was later announced that Dr. Aileen Wang from the Philippine General Hospital (PGH) will be the driving force behind the clinical trials. The trials will involve quarantine centers near PGH.
Earlier on April 10, 2021, the government claimed that there were no plans to conduct the trials to determine the efficacy of the anti-parasitic drug against the COVID-19 pandemic because similar studies were being conducted in different parts of the world.
However, the Department of Health (DOH) has already allocated funds for the clinical trials, dela Peña noted.
Dela Peña expressed his hopes that following the clinical trials, more reliable estimates of the effects of ivermectin as an anti-viral agent will appear, especially in reducing the virus shedding in mild to moderate patients.
But he said the program could run for six months, depending on the number of volunteers who will join the program.